-
1
-
-
79955768010
-
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system
-
Kohler, B. A.; Ward, E.; McCarthy, B. J.; Schymura, M. J.; Ries, L. A.; Eheman, C.; Jemal, A.; Anderson, R. N.; Ajani, U. A.; Edwards, B. K. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system J. Natl. Cancer Inst. 2011, 103, 714-736
-
(2011)
J. Natl. Cancer Inst.
, vol.103
, pp. 714-736
-
-
Kohler, B.A.1
Ward, E.2
McCarthy, B.J.3
Schymura, M.J.4
Ries, L.A.5
Eheman, C.6
Jemal, A.7
Anderson, R.N.8
Ajani, U.A.9
Edwards, B.K.10
-
2
-
-
0031018888
-
Isolation and characterization of human malignant glioma cells from histologically normal brain
-
Silbergeld, D. L.; Chicoine, M. R. Isolation and characterization of human malignant glioma cells from histologically normal brain J. Neurosurg. 1997, 86, 525-531
-
(1997)
J. Neurosurg.
, vol.86
, pp. 525-531
-
-
Silbergeld, D.L.1
Chicoine, M.R.2
-
3
-
-
78651423627
-
Experimental approaches for the treatment of malignant gliomas
-
Arko, L.; Katsyv, I.; Park, G. E.; Luan, W. P.; Park, J. K. Experimental approaches for the treatment of malignant gliomas Pharmacol. Ther. 2010, 128, 1-36
-
(2010)
Pharmacol. Ther.
, vol.128
, pp. 1-36
-
-
Arko, L.1
Katsyv, I.2
Park, G.E.3
Luan, W.P.4
Park, J.K.5
-
4
-
-
77956344034
-
Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches
-
Cardoso, F. L.; Brites, D.; Brito, M. A. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches Brain Res. Rev. 2010, 64, 328-363
-
(2010)
Brain Res. Rev.
, vol.64
, pp. 328-363
-
-
Cardoso, F.L.1
Brites, D.2
Brito, M.A.3
-
5
-
-
0042899083
-
Blood-brain barrier drug targeting: The future of brain drug development
-
Pardridge, W. M. Blood-brain barrier drug targeting: the future of brain drug development Mol. Interv. 2003, 3, 90-105
-
(2003)
Mol. Interv.
, vol.3
, pp. 90-105
-
-
Pardridge, W.M.1
-
6
-
-
84862090881
-
Recent advances in brain tumor-targeted nano-drug delivery systems
-
Liu, Y.; Lu, W. Recent advances in brain tumor-targeted nano-drug delivery systems Expert Opin. Drug Delivery 2012, 9, 671-686
-
(2012)
Expert Opin. Drug Delivery
, vol.9
, pp. 671-686
-
-
Liu, Y.1
Lu, W.2
-
7
-
-
0036260753
-
Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels
-
Ningaraj, N. S.; Rao, M.; Hashizume, K.; Asotra, K.; Black, K. L. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels J. Pharmacol. Exp. Ther. 2002, 301, 838-851
-
(2002)
J. Pharmacol. Exp. Ther.
, vol.301
, pp. 838-851
-
-
Ningaraj, N.S.1
Rao, M.2
Hashizume, K.3
Asotra, K.4
Black, K.L.5
-
8
-
-
70349988803
-
PEG conjugates in clinical development or use as anticancer agents: An overview
-
Pasut, G.; Veronese, F. M. PEG conjugates in clinical development or use as anticancer agents: an overview Adv. Drug Delivery Rev. 2009, 61, 1177-1188
-
(2009)
Adv. Drug Delivery Rev.
, vol.61
, pp. 1177-1188
-
-
Pasut, G.1
Veronese, F.M.2
-
9
-
-
78649924497
-
Targeted imaging and therapy of brain cancer using theranostic nanoparticles
-
Bhojani, M. S.; Van Dort, M.; Rehemtulla, A.; Ross, B. D. Targeted imaging and therapy of brain cancer using theranostic nanoparticles Mol. Pharmaceutics 2010, 7, 1921-1929
-
(2010)
Mol. Pharmaceutics
, vol.7
, pp. 1921-1929
-
-
Bhojani, M.S.1
Van Dort, M.2
Rehemtulla, A.3
Ross, B.D.4
-
10
-
-
34548427504
-
Active targeting of brain tumors using nanocarriers
-
Beduneau, A.; Saulnier, P.; Benoit, J. P. Active targeting of brain tumors using nanocarriers Biomaterials 2007, 28, 4947-4967
-
(2007)
Biomaterials
, vol.28
, pp. 4947-4967
-
-
Beduneau, A.1
Saulnier, P.2
Benoit, J.P.3
-
11
-
-
0036781811
-
Ligand-targeted therapeutics in anticancer therapy
-
Allen, T. M. Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2002, 2, 750-763
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 750-763
-
-
Allen, T.M.1
-
12
-
-
1242271302
-
Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress
-
Marcucci, F.; Lefoulon, F. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress Drug Discovery Today 2004, 9, 219-228
-
(2004)
Drug Discovery Today
, vol.9
, pp. 219-228
-
-
Marcucci, F.1
Lefoulon, F.2
-
13
-
-
3342880250
-
Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse
-
Suzuki, Y. A.; Lonnerdal, B. Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse Biometals 2004, 17, 301-309
-
(2004)
Biometals
, vol.17
, pp. 301-309
-
-
Suzuki, Y.A.1
Lonnerdal, B.2
-
14
-
-
0021677758
-
Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins
-
Metz-Boutigue, M. H.; Jolles, J.; Mazurier, J.; Schoentgen, F.; Legrand, D.; Spik, G.; Montreuil, J.; Jolles, P. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins Eur. J. Biochem. 1984, 145, 659-676
-
(1984)
Eur. J. Biochem.
, vol.145
, pp. 659-676
-
-
Metz-Boutigue, M.H.1
Jolles, J.2
Mazurier, J.3
Schoentgen, F.4
Legrand, D.5
Spik, G.6
Montreuil, J.7
Jolles, P.8
-
15
-
-
84861402079
-
Lactoferrin - 50 years on
-
Brock, J. H. Lactoferrin-50 years on Biochem. Cell Biol. 2012, 90, 245-51
-
(2012)
Biochem. Cell Biol.
, vol.90
, pp. 245-251
-
-
Brock, J.H.1
-
16
-
-
28344453346
-
Mammalian lactoferrin receptors: Structure and function
-
Suzuki, Y. A.; Lopez, V.; Lonnerdal, B. Mammalian lactoferrin receptors: structure and function Cell. Mol. Life Sci. 2005, 62, 2560-2575
-
(2005)
Cell. Mol. Life Sci.
, vol.62
, pp. 2560-2575
-
-
Suzuki, Y.A.1
Lopez, V.2
Lonnerdal, B.3
-
17
-
-
33847148508
-
Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain
-
Huang, R. Q.; Ke, W. L.; Qu, Y. H.; Zhu, J. H.; Pei, Y. Y.; Jiang, C. Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain J. Biomed. Sci. 2007, 14, 121-128
-
(2007)
J. Biomed. Sci.
, vol.14
, pp. 121-128
-
-
Huang, R.Q.1
Ke, W.L.2
Qu, Y.H.3
Zhu, J.H.4
Pei, Y.Y.5
Jiang, C.6
-
18
-
-
84865340231
-
Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles
-
Lalani, J.; Raichandani, Y.; Mathur, R.; Lalan, M.; Chutani, K.; Mishra, A. K.; Misra, A. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles J. Biomed. Nanotechnol. 2012, 8, 918-927
-
(2012)
J. Biomed. Nanotechnol.
, vol.8
, pp. 918-927
-
-
Lalani, J.1
Raichandani, Y.2
Mathur, R.3
Lalan, M.4
Chutani, K.5
Mishra, A.K.6
Misra, A.7
-
19
-
-
84877067774
-
Protein functionalized tramadol-loaded PLGA nanoparticles: Preparation, optimization, stability and pharmacodynamic studies
-
Lalani, J.; Rathi, M.; Lalan, M.; Misra, A. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies Drug Dev. Ind. Pharm. 2013, 39, 854-864
-
(2013)
Drug Dev. Ind. Pharm.
, vol.39
, pp. 854-864
-
-
Lalani, J.1
Rathi, M.2
Lalan, M.3
Misra, A.4
-
20
-
-
77952239864
-
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery
-
Chen, H.; Tang, L.; Qin, Y.; Yin, Y.; Tang, J.; Tang, W.; Sun, X.; Zhang, Z.; Liu, J.; He, Q. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery Eur. J. Pharm. Sci. 2010, 40, 94-102
-
(2010)
Eur. J. Pharm. Sci.
, vol.40
, pp. 94-102
-
-
Chen, H.1
Tang, L.2
Qin, Y.3
Yin, Y.4
Tang, J.5
Tang, W.6
Sun, X.7
Zhang, Z.8
Liu, J.9
He, Q.10
-
21
-
-
35548959221
-
The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain
-
Huang, R.; Ke, W.; Liu, Y.; Jiang, C.; Pei, Y. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain Biomaterials 2008, 29, 238-246
-
(2008)
Biomaterials
, vol.29
, pp. 238-246
-
-
Huang, R.1
Ke, W.2
Liu, Y.3
Jiang, C.4
Pei, Y.5
-
22
-
-
0342368730
-
Human glioblastoma cell lines: Levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein
-
Maletinska, L.; Blakely, E. A.; Bjornstad, K. A.; Deen, D. F.; Knoff, L. J.; Forte, T. M. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein Cancer Res. 2000, 60, 2300-2303
-
(2000)
Cancer Res.
, vol.60
, pp. 2300-2303
-
-
Maletinska, L.1
Blakely, E.A.2
Bjornstad, K.A.3
Deen, D.F.4
Knoff, L.J.5
Forte, T.M.6
-
23
-
-
48749095941
-
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2
-
Demeule, M.; Currie, J. C.; Bertrand, Y.; Che, C.; Nguyen, T.; Regina, A.; Gabathuler, R.; Castaigne, J. P.; Beliveau, R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2 J. Neurochem. 2008, 106, 1534-1544
-
(2008)
J. Neurochem.
, vol.106
, pp. 1534-1544
-
-
Demeule, M.1
Currie, J.C.2
Bertrand, Y.3
Che, C.4
Nguyen, T.5
Regina, A.6
Gabathuler, R.7
Castaigne, J.P.8
Beliveau, R.9
-
24
-
-
0036514256
-
Diverse roles for the LDL receptor family
-
Strickland, D. K.; Gonias, S. L.; Argraves, W. S. Diverse roles for the LDL receptor family Trends Endocrinol. Metab. 2002, 13, 66-74
-
(2002)
Trends Endocrinol. Metab.
, vol.13
, pp. 66-74
-
-
Strickland, D.K.1
Gonias, S.L.2
Argraves, W.S.3
-
25
-
-
0034692118
-
Cell delivery to the central nervous system
-
Shoichet, M. S.; Winn, S. R. Cell delivery to the central nervous system Adv. Drug Delivery Rev. 2000, 42, 81-102
-
(2000)
Adv. Drug Delivery Rev.
, vol.42
, pp. 81-102
-
-
Shoichet, M.S.1
Winn, S.R.2
-
26
-
-
84862698355
-
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
-
Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Controlled Release 2012, 161, 175-187
-
(2012)
J. Controlled Release
, vol.161
, pp. 175-187
-
-
Lammers, T.1
Kiessling, F.2
Hennink, W.E.3
Storm, G.4
-
28
-
-
84861160747
-
Nanocarriers to solid tumors: Considerations on tumor penetration and exposure of tumor cells to therapeutic agents
-
Bhagat, M.; Halligan, S.; Sofou, S. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents Curr. Pharm. Biotechnol. 2012, 13, 1306-1316
-
(2012)
Curr. Pharm. Biotechnol.
, vol.13
, pp. 1306-1316
-
-
Bhagat, M.1
Halligan, S.2
Sofou, S.3
-
29
-
-
84864125045
-
Peptides as targeting elements and tissue penetration devices for nanoparticles
-
Ruoslahti, E. Peptides as targeting elements and tissue penetration devices for nanoparticles Adv. Mater. 2012, 24, 3747-3756
-
(2012)
Adv. Mater.
, vol.24
, pp. 3747-3756
-
-
Ruoslahti, E.1
-
30
-
-
84865258883
-
Transtumoral targeting enabled by a novel neuropilin-binding peptide
-
Roth, L.; Agemy, L.; Kotamraju, V. R.; Braun, G.; Teesalu, T.; Sugahara, K. N.; Hamzah, J.; Ruoslahti, E. Transtumoral targeting enabled by a novel neuropilin-binding peptide Oncogene 2012, 31, 3754-3763
-
(2012)
Oncogene
, vol.31
, pp. 3754-3763
-
-
Roth, L.1
Agemy, L.2
Kotamraju, V.R.3
Braun, G.4
Teesalu, T.5
Sugahara, K.N.6
Hamzah, J.7
Ruoslahti, E.8
-
31
-
-
79952407244
-
Binding of a C-end rule peptide to the neuropilin-1 receptor: A molecular modeling approach
-
Haspel, N.; Zanuy, D.; Nussinov, R.; Teesalu, T.; Ruoslahti, E.; Aleman, C. Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach Biochemistry 2011, 50, 1755-1762
-
(2011)
Biochemistry
, vol.50
, pp. 1755-1762
-
-
Haspel, N.1
Zanuy, D.2
Nussinov, R.3
Teesalu, T.4
Ruoslahti, E.5
Aleman, C.6
-
32
-
-
70349482671
-
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
-
Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 16157-16162
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 16157-16162
-
-
Teesalu, T.1
Sugahara, K.N.2
Kotamraju, V.R.3
Ruoslahti, E.4
-
33
-
-
2442639176
-
Neuropilin-1 in human colon cancer: Expression, regulation, and role in induction of angiogenesis
-
Parikh, A. A.; Fan, F.; Liu, W. B.; Ahmad, S. A.; Stoeltzing, O.; Reinmuth, N.; Bielenberg, D.; Bucana, C. D.; Klagsbrun, M.; Ellis, L. M. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis Am. J. Pathol. 2004, 164, 2139-2151
-
(2004)
Am. J. Pathol.
, vol.164
, pp. 2139-2151
-
-
Parikh, A.A.1
Fan, F.2
Liu, W.B.3
Ahmad, S.A.4
Stoeltzing, O.5
Reinmuth, N.6
Bielenberg, D.7
Bucana, C.D.8
Klagsbrun, M.9
Ellis, L.M.10
-
34
-
-
0033766256
-
Expression and regulation of neuropilin-1 in human astrocytomas
-
Ding, H.; Wu, X.; Roncari, L.; Lau, N.; Shannon, P.; Nagy, A.; Guha, A. Expression and regulation of neuropilin-1 in human astrocytomas Int. J. Cancer 2000, 88, 584-592
-
(2000)
Int. J. Cancer
, vol.88
, pp. 584-592
-
-
Ding, H.1
Wu, X.2
Roncari, L.3
Lau, N.4
Shannon, P.5
Nagy, A.6
Guha, A.7
-
35
-
-
84869211914
-
Neuropilin-1 dependent regulation of EGF-Receptor signaling
-
Rizzolio, S.; Rabinowicz, N.; Rainero, E.; Lanzetti, L.; Serini, G.; Norman, J. C.; Neufeld, G.; Tamagnone, L. Neuropilin-1 dependent regulation of EGF-Receptor signaling Cancer Res. 2012, 72, 5801-5811
-
(2012)
Cancer Res.
, vol.72
, pp. 5801-5811
-
-
Rizzolio, S.1
Rabinowicz, N.2
Rainero, E.3
Lanzetti, L.4
Serini, G.5
Norman, J.C.6
Neufeld, G.7
Tamagnone, L.8
-
36
-
-
77950515941
-
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
-
Zhan, C.; Gu, B.; Xie, C.; Li, J.; Liu, Y.; Lu, W. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect J. Controlled Release 2010, 143, 136-142
-
(2010)
J. Controlled Release
, vol.143
, pp. 136-142
-
-
Zhan, C.1
Gu, B.2
Xie, C.3
Li, J.4
Liu, Y.5
Lu, W.6
-
37
-
-
33747086988
-
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma
-
Son, M. J.; Song, H. S.; Kim, M. H.; Kim, J. T.; Kang, C. M.; Jeon, J. W.; Park, S. Y.; Kim, Y. J.; Groves, M. D.; Park, K.; Kim, J. H.; Nam, D. H. Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma Int. J. Oncol. 2006, 28, 1385-1392
-
(2006)
Int. J. Oncol.
, vol.28
, pp. 1385-1392
-
-
Son, M.J.1
Song, H.S.2
Kim, M.H.3
Kim, J.T.4
Kang, C.M.5
Jeon, J.W.6
Park, S.Y.7
Kim, Y.J.8
Groves, M.D.9
Park, K.10
Kim, J.H.11
Nam, D.H.12
-
38
-
-
51349102460
-
Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
-
Régina, A.; Demeule, M.; Ché, C.; Lavallée, I.; Poirier, J.; Gabathuler, R.; Béliveau, R.; Castaigne, J. P. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2 Br. J. Pharmacol. 2008, 155, 185-197
-
(2008)
Br. J. Pharmacol.
, vol.155
, pp. 185-197
-
-
Régina, A.1
Demeule, M.2
Ché, C.3
Lavallée, I.4
Poirier, J.5
Gabathuler, R.6
Béliveau, R.7
Castaigne, J.P.8
-
39
-
-
36049049858
-
Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme
-
Nikanjam, M.; Gibbs, A. R.; Hunt, C. A.; Budinger, T. F.; Forte, T. M. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme J. Controlled Release 2007, 124, 163-171
-
(2007)
J. Controlled Release
, vol.124
, pp. 163-171
-
-
Nikanjam, M.1
Gibbs, A.R.2
Hunt, C.A.3
Budinger, T.F.4
Forte, T.M.5
-
40
-
-
0037139411
-
Paclitaxel and its formulations
-
Singla, A. K.; Garg, A.; Aggarwal, D. Paclitaxel and its formulations Int. J. Pharmaceutics 2002, 235, 179-192
-
(2002)
Int. J. Pharmaceutics
, vol.235
, pp. 179-192
-
-
Singla, A.K.1
Garg, A.2
Aggarwal, D.3
-
41
-
-
34547655840
-
Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration
-
Gao, X.; Wu, B.; Zhang, Q.; Chen, J.; Zhu, J.; Zhang, W.; Rong, Z.; Chen, H.; Jiang, X. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration J. Controlled Release 2007, 121, 156-617
-
(2007)
J. Controlled Release
, vol.121
, pp. 156-617
-
-
Gao, X.1
Wu, B.2
Zhang, Q.3
Chen, J.4
Zhu, J.5
Zhang, W.6
Rong, Z.7
Chen, H.8
Jiang, X.9
-
42
-
-
84870367372
-
Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: Cellular interaction and in vivo absorption
-
Zeng, N.; Gao, X.; Hu, Q.; Song, Q.; Xia, H.; Liu, Z.; Gu, G.; Jiang, M.; Pang, Z.; Chen, H.; Chen, J.; Fang, L. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption Int. J. Nanomed. 2012, 7, 3703-3718
-
(2012)
Int. J. Nanomed.
, vol.7
, pp. 3703-3718
-
-
Zeng, N.1
Gao, X.2
Hu, Q.3
Song, Q.4
Xia, H.5
Liu, Z.6
Gu, G.7
Jiang, M.8
Pang, Z.9
Chen, H.10
Chen, J.11
Fang, L.12
-
43
-
-
84865558062
-
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles
-
Xin, H.; Sha, X.; Jiang, X.; Zhang, W.; Chen, L.; Fang, X. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles Biomaterials 2012, 33, 8167-8176
-
(2012)
Biomaterials
, vol.33
, pp. 8167-8176
-
-
Xin, H.1
Sha, X.2
Jiang, X.3
Zhang, W.4
Chen, L.5
Fang, X.6
-
44
-
-
84868121994
-
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy
-
Gu, G.; Xia, H.; Hu, Q.; Liu, Z.; Jiang, M.; Kang, T.; Miao, D.; Tu, Y.; Pang, Z.; Song, Q.; Yao, L.; Chen, H.; Gao, X.; Chen, J. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy Biomaterials 2013, 34, 196-208
-
(2013)
Biomaterials
, vol.34
, pp. 196-208
-
-
Gu, G.1
Xia, H.2
Hu, Q.3
Liu, Z.4
Jiang, M.5
Kang, T.6
Miao, D.7
Tu, Y.8
Pang, Z.9
Song, Q.10
Yao, L.11
Chen, H.12
Gao, X.13
Chen, J.14
-
45
-
-
80051817418
-
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery
-
Guo, J.; Gao, X.; Su, L.; Xia, H.; Gu, G.; Pang, Z.; Jiang, X.; Yao, L.; Chen, J.; Chen, H. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery Biomaterials 2011, 32, 8010-8020
-
(2011)
Biomaterials
, vol.32
, pp. 8010-8020
-
-
Guo, J.1
Gao, X.2
Su, L.3
Xia, H.4
Gu, G.5
Pang, Z.6
Jiang, X.7
Yao, L.8
Chen, J.9
Chen, H.10
-
46
-
-
57449121882
-
Getting into the brain: Approaches to enhance brain drug delivery
-
Patel, M. M.; Goyal, B. R.; Bhadada, S. V.; Bhatt, J. S.; Amin, A. F. Getting into the brain: approaches to enhance brain drug delivery CNS Drugs 2009, 23, 35-58
-
(2009)
CNS Drugs
, vol.23
, pp. 35-58
-
-
Patel, M.M.1
Goyal, B.R.2
Bhadada, S.V.3
Bhatt, J.S.4
Amin, A.F.5
-
47
-
-
72149109532
-
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
-
Ying, X.; Wen, H.; Lu, W. L.; Du, J.; Guo, J.; Tian, W.; Men, Y.; Zhang, Y.; Li, R. J.; Yang, T. Y.; Shang, D. W.; Lou, J. N.; Zhang, L. R.; Zhang, Q. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Controlled Release 2010, 141, 183-192
-
(2010)
J. Controlled Release
, vol.141
, pp. 183-192
-
-
Ying, X.1
Wen, H.2
Lu, W.L.3
Du, J.4
Guo, J.5
Tian, W.6
Men, Y.7
Zhang, Y.8
Li, R.J.9
Yang, T.Y.10
Shang, D.W.11
Lou, J.N.12
Zhang, L.R.13
Zhang, Q.14
-
48
-
-
79955104821
-
Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma
-
Xin, H.; Jiang, X.; Gu, J.; Sha, X.; Chen, L.; Law, K.; Chen, Y.; Wang, X.; Jiang, Y.; Fang, X. Angiopep-conjugated poly(ethylene glycol)-co- poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma Biomaterials 2011, 32, 4293-4305
-
(2011)
Biomaterials
, vol.32
, pp. 4293-4305
-
-
Xin, H.1
Jiang, X.2
Gu, J.3
Sha, X.4
Chen, L.5
Law, K.6
Chen, Y.7
Wang, X.8
Jiang, Y.9
Fang, X.10
-
49
-
-
70749103751
-
Tissue-penetrating delivery of compounds and nanoparticles into tumors
-
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 2009, 16, 510-520
-
(2009)
Cancer Cell
, vol.16
, pp. 510-520
-
-
Sugahara, K.N.1
Teesalu, T.2
Karmali, P.P.3
Kotamraju, V.R.4
Agemy, L.5
Girard, O.M.6
Hanahan, D.7
Mattrey, R.F.8
Ruoslahti, E.9
-
50
-
-
77952901022
-
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
-
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 2010, 328, 1031-1035
-
(2010)
Science
, vol.328
, pp. 1031-1035
-
-
Sugahara, K.N.1
Teesalu, T.2
Karmali, P.P.3
Kotamraju, V.R.4
Agemy, L.5
Greenwald, D.R.6
Ruoslahti, E.7
-
51
-
-
0036690684
-
Synthesis of pegylated immunonanoparticles
-
Olivier, J. C.; Huertas, R.; Lee, H. J.; Calon, F.; Pardridge, W. M. Synthesis of pegylated immunonanoparticles Pharm. Res. 2002, 19, 1137-1143
-
(2002)
Pharm. Res.
, vol.19
, pp. 1137-1143
-
-
Olivier, J.C.1
Huertas, R.2
Lee, H.J.3
Calon, F.4
Pardridge, W.M.5
-
52
-
-
51049104302
-
Pharmacokinetics and biodistribution of nanoparticles
-
Li, S. D.; Huang, L. Pharmacokinetics and biodistribution of nanoparticles Mol. Pharmaceutics 2008, 5, 496-504
-
(2008)
Mol. Pharmaceutics
, vol.5
, pp. 496-504
-
-
Li, S.D.1
Huang, L.2
-
53
-
-
84865000013
-
Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma
-
Shi, L.; Tang, C.; Yin, C. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma Biomaterials 2012, 33, 7594-7604
-
(2012)
Biomaterials
, vol.33
, pp. 7594-7604
-
-
Shi, L.1
Tang, C.2
Yin, C.3
-
54
-
-
77955769665
-
Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier
-
Gan, C. W.; Feng, S. S. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier Biomaterials 2010, 31, 7748-7757
-
(2010)
Biomaterials
, vol.31
, pp. 7748-7757
-
-
Gan, C.W.1
Feng, S.S.2
-
55
-
-
84864025934
-
Mechanisms of transcellular transport of wheat germ agglutinin- functionalized polymeric nanoparticles in Caco-2 cells
-
Song, Q.; Yao, L.; Huang, M.; Hu, Q.; Lu, Q.; Wu, B.; Qi, H.; Rong, Z.; Jiang, X.; Gao, X.; Chen, J.; Chen, H. Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells Biomaterials 2012, 33, 6769-6782
-
(2012)
Biomaterials
, vol.33
, pp. 6769-6782
-
-
Song, Q.1
Yao, L.2
Huang, M.3
Hu, Q.4
Lu, Q.5
Wu, B.6
Qi, H.7
Rong, Z.8
Jiang, X.9
Gao, X.10
Chen, J.11
Chen, H.12
|